Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus
- PMID: 12236779
- DOI: 10.1021/bc025559y
Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus
Abstract
The subcellular fate and activity in inhibiting the hepatitis B virus of free and N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-phosphorothioate oligonucleotides were studied. Their internalization and subcellular fate were monitored with confocal microscopy. A fraction of the internalized free oligonucleotides escaped into the cytoplasm and nucleus of Hep G2 cells but were not active antiviral agents. Covalently attaching the oligonucleotides to the HPMA copolymers via nondegradable dipeptide GG spacers resulted in sequestering the oligonucleotides in vesicles after internalization. Conjugation of the oligonucleotides to an HPMA copolymer via a lysosomally cleavable tetrapeptide GFLG spacer resulted in release of the oligonucleotide in the lysosome and subsequent translocation into the cytoplasm and nucleus of the cells. The HPMA copolymer-oligonucleotide conjugate possessed antiviral activity, indicating that phosphorothioate oligonucleotides released from the carrier in the lysosome were able to escape into the cytoplasm and nucleus and remain active. The Hep G2 cells appeared to actively internalize the phosphorothioate oligonucleotides as oligonucleotide-HPMA copolymer conjugates were internalized to a greater extent than unconjugated polymers.
Similar articles
-
Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.J Control Release. 2003 Feb 21;87(1-3):89-105. doi: 10.1016/s0168-3659(02)00352-8. J Control Release. 2003. PMID: 12618026 Review.
-
Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.Pharm Res. 2003 May;20(5):728-37. doi: 10.1023/a:1023425300829. Pharm Res. 2003. PMID: 12751627
-
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.Int J Cancer. 1998 Feb 9;75(4):600-8. doi: 10.1002/(sici)1097-0215(19980209)75:4<600::aid-ijc18>3.0.co;2-c. Int J Cancer. 1998. PMID: 9466663
-
Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.Photochem Photobiol. 2003 Jun;77(6):645-52. doi: 10.1562/0031-8655(2003)077<0645:mociho>2.0.co;2. Photochem Photobiol. 2003. PMID: 12870851
-
Designing polymer conjugates as lysosomotropic nanomedicines.Biochem Soc Trans. 2007 Feb;35(Pt 1):56-60. doi: 10.1042/BST0350056. Biochem Soc Trans. 2007. PMID: 17233601 Review.
Cited by
-
Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine.World J Gastroenterol. 2003 Jun;9(6):1251-5. doi: 10.3748/wjg.v9.i6.1251. World J Gastroenterol. 2003. PMID: 12800234 Free PMC article.
-
HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells.Bioconjug Chem. 2009 Feb;20(2):213-21. doi: 10.1021/bc800237t. Bioconjug Chem. 2009. PMID: 19133717 Free PMC article.
-
Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.Nanomedicine (Lond). 2008 Apr;3(2):247-65. doi: 10.2217/17435889.3.2.247. Nanomedicine (Lond). 2008. PMID: 18373429 Free PMC article. Review.
-
Drugs in Development for Hepatitis B.Drugs. 2017 Aug;77(12):1263-1280. doi: 10.1007/s40265-017-0769-2. Drugs. 2017. PMID: 28660478 Free PMC article. Review.
-
HPMA copolymers: origins, early developments, present, and future.Adv Drug Deliv Rev. 2010 Feb 17;62(2):122-49. doi: 10.1016/j.addr.2009.10.004. Epub 2009 Nov 14. Adv Drug Deliv Rev. 2010. PMID: 19919846 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
